Download
HTML Embed
HTML EMBED
Click to Copy

Latest Episodes

Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy

Why do foreign countries pay less than the U.S. for prescription drugs?

by Amy Scott Jul 9, 2019
The answer comes down to one key tactic: negotiation.
A pharmacy's green cross sign in Nantes, western France.
LOIC VENANCE/AFP/Getty Images

Another pharma megamerger: AbbVie buys Allergan for $63 billion

by Erika Beras Jun 25, 2019
Both companies are under pressure to improve their performance.
PHILIPPE HUGUEN/AFP/Getty Images

Would requiring prices in pharmaceutical ads make drugs cheaper?

by Andy Uhler Apr 9, 2019
The idea is that transparency would lead to more competition and lower costs. One drug company is already on board.
Philippe Huguen/AFP/Getty Images

Walgreens has a tough quarter

by Jack Stewart Apr 2, 2019
Pharmacy chain Walgreens reported a 3.8 percent drop in sales for the quarter. The company cited a weak cough, cold and flu season — and declining profits from generic and branded prescription drugs. Click the audio player above to hear…
People walk by a Walgreens store in San Francisco. The pharmacy industry thinks bigger is better to find cost savings.
Justin Sullivan/Getty Images

Pharma executives in the hot seat over drug prices

by Erika Beras Feb 26, 2019
Senior leaders of big pharmaceutical companies are in D.C. Tuesday to testify before a Senate committee.
jorgeantonio/iStock/Getty Images Plus

Big Pharma is betting big on cancer drugs

by Nancy Marshall-Genzer Jan 3, 2019
Bristol-Myers Squibb announced Thursday that it’s going to acquire another drugmaker, Celgene. The deal is worth about $74 billion. The combined company will have nine products with sales of more than a billion dollars a year, including some blockbuster cancer…
pxhere

"Pharma Bro" Martin Shkreli is convicted at securities fraud trial

by Marketplace Contributor Aug 4, 2017
“They blame me for capitalism,” said Martin Shkreli.
Martin Shkreli, former CEO of Turing Pharmaceuticals, exits federal court in the Brooklyn borough of New York City. 
Eduardo Munoz Alvarez/Getty Images

Invest in Marketplace today

Ask not what Marketplace can do for you, but what you can do for Marketplace.

The Big Book

You can stop saying 'iconic' now

by Bridget Bodnar Jun 15, 2017
Humorist and language fussbudget Jenny Allen wants to squash these overused words and phrases.
KAREN BLEIER/AFP/Getty Images

Trump tells big pharma to cut their 'astronomical' drug prices

by David Brancaccio Feb 1, 2017
Will drug companies agree to the president's proposal?
 President Donald Trump meets with representatives from PhRMA, the Pharmaceutical Research and Manufacturers of America, on Tuesday.
Ron Sachs - Pool/Getty Images

New class of generics could save consumers, insurers billions. FDA is moving carefully.

by Dan Gorenstein Jul 13, 2016
The European Union has some 20 "biosimilar" generics on the market; the US has one.
Pre-filled syringes of  the adalimumab biosimilar.  The biosimilar is used in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis and ankylosing spondylitis.
SAM PANTHAKY/AFP/Getty Images